Accuray at ASTRO 2023
Certainty Matters.
As healthcare providers face unprecedented changes, certainty matters more than ever. At ASTRO 2023, see how our advanced technology can help give clinicians the tools to deliver personalized treatments with best-in-class clinical workflows. How clinical evidence gives patients greater certainty that they’re getting the best possible treatment. And how that combination of powerful technology and clinical evidence give healthcare organizations greater certainty to make confident investments to drive future success.
Transform your practice with Accuray Adaptive Suite
Join AEx for an Exciting Educational Program at ASTRO!
We are excited to announce that our upcoming presentations will be live and streamed, allowing attendees worldwide to participate and gain valuable insights into the latest developments in radiation oncology. Our program is designed to provide an educational experience that covers a wide range of topics related to the CyberKnife®, Radixact® and TomoTherapy® platforms. Whether you are a seasoned professional or just starting your career, we are confident that you will find our program informative, engaging, and highly beneficial. So, mark your calendars and join us for this exciting opportunity to learn from your peers.
The Radixact® System, a Comprehensive
Breast Cancer System
Visit Accuray ASTRO to see how the innovative VitalHold* Breast Package gives clinicians the certainty to treat virtually all breast cancer cases with the Radixact System — maximizing patient comfort and optimizing patient outcomes.
Talk to an Expert
Accuray Symposium
Expert Encounters: A Live Debate on the Merits and Controversies of SBRT and ADT in the Management of Prostate Cancer
Join us at our symposium hosted at ASTRO for two invigorating debates that delve into the forefront of prostate cancer therapies. Prepare to engage as we navigate through contrasting perspectives on topics that are reshaping the trajectory of modern prostate cancer treatment with SBRT and ADT.  This event promises to be a platform for lively exchange, allowing radiation oncologists, physicists, radiation therapists, and nurses to broaden their perspectives.  Share in compelling discussions as Radiation Oncologist thought leaders debate differing viewpoints on contemporary topics that highly impact prostate cancer care. Â
Introduction & Conclusion
Dr. Seth Blacksburg, SVP, Chief Medical Officer, Accuray
Debate #1 Moderated by Dr. Jon Haas
ADT is a Critical Component in the Management of UPCa in the Modern Era.
Dr. Amar Kishan vs Dr. Mack Roach
Debate #2 Moderated by Seth Blacksburg
Prostate SBRT has emerged as the ablative therapy of choice for the majority of prostate cancer.
Dr. Richard Stock vs Dr. Robert Timmerman
510(k) Pending. Online Adaptive on the Radixact® System is not available for sale in the USA. It is not CE marked and availability is subject to regulatory clearance or approval in some markets.
